皮内电穿孔递送TcVac1疫苗增强小鼠抗克氏锥虫感染免疫保护
研究在BALB/c小鼠模型中比较TcVac1(TcG2与TcG4抗原)DNA初免/加强疫苗经皮内电穿孔(IDE)与肌内(IM)递送的免疫效果。结果显示IDE递送诱导更高水平的抗原特异性抗体反应(IgG2a+IgG2b>IgG1)和淋巴细胞增殖,并增强组织炎症浸润与无鞭毛体巢控制,提示IDE递送可提高TcVac1对克氏锥虫感染的保护效力。
要点
- IDE递送TcVac1诱导的抗原特异性抗体以IgG2a+IgG2b为主,优于IgG1。
- IDE递送组淋巴细胞增殖反应更强,且随攻击感染而扩增。
- 组织炎症浸润程度与感染小鼠组织无鞭毛体巢控制直接相关。
核心结论
- 与IM递送相比,IDE递送可提高TcVac1疫苗对小鼠克氏锥虫感染的保护效力。
研究设计与样本
- 在BALB/c小鼠模型中,将TcVac1(TcG2与TcG4抗原)经IDE或IM途径免疫,随后以克氏锥虫攻击感染,于急性期评估。
主要发现
- IDE递送TcVac1诱导的抗原特异性抗体水平(IgG2a+IgG2b>IgG1)和淋巴细胞增殖显著高于IM递送。
- 攻击感染后所有感染小鼠心脏和骨骼组织均见炎症细胞(巨噬细胞和淋巴细胞)浸润。
- TcVac1_IDE/Tc小鼠炎症浸润增加最大,且组织炎症浸润程度与无鞭毛体巢控制直接相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The efforts for the development and testing of vaccines against Trypanosoma cruzi infection have increased during the past years. We have designed a TcVac series of vaccines composed of T. cruzi derived, GPI-anchored membrane antigens. The TcVac vaccines have been shown to elicit humoral and cellular mediated immune responses and provide significant (but not complete) control of experimental infection in mice and dogs. Herein, we aimed to test two immunization protocols for the delivery of DNA-prime/DNA-boost vaccine (TcVac1) composed of TcG2 and TcG4 antigens in a BALB/c mouse model. Mice were immunized with TcVac1 through intradermal/electroporation (IDE) or intramuscular (IM) routes, challenged with T. cruzi, and evaluated during acute phase of infection. The humoral immune response was evaluated through the assessment of anti-TcG2 and anti-TcG4 IgG subtypes by using an ELISA. Cellular immune response was assessed through a lymphocyte proliferation assay. Finally, clinical and morphopathological aspects were evaluated for all experimental animals. Our results demonstrated that when comparing TcVac1 IDE delivery vs IM delivery, the former induced significantly higher level of antigen-specific antibody response (IgG2a + IgG2b > IgG1) and lymphocyte proliferation, which expanded in response to challenge infection. Histological evaluation after challenge infection showed infiltration of inflammatory cells (macrophages and lymphocytes) in the heart and skeletal tissue of all infected mice. However, the largest increase in inflammatory infiltrate was observed in TcVac1_IDE/Tc mice when compared with TcVac1_IM/Tc or non-vaccinated/infected mice. The extent of tissue inflammatory infiltrate was directly associated with the control of tissue amastigote nests in vaccinated/infected (vs. non-vaccinated/infected) mice. Our results suggest that IDE delivery improves the protective efficacy of TcVac1 vaccine against T. cruzi infection in mice when compared with IM delivery of the vaccine.
引用
- Hegazy-Hassan W, Zepeda-Escobar JA, Ochoa-García L, et al. TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice. Vaccine. 2018. PMID: 30497833. doi:10.1016/j.vaccine.2018.11.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。